Substituted 4-phenyl piperidines for use as renin inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S105000

Reexamination Certificate

active

07625893

ABSTRACT:
Compounds of the general formula (I) and the salts thereof, preferably the pharmaceutically acceptable salts thereof; in which R1is straight-chain C1-8-alkanoyloxy, straight-chain C1-8-alkoxy, straight-chain C1-8-alkoxy-straight-chain-C1-8-alkoxy, straight-chain C1-8-alkoxycarbonylamino, straight-chain C0-8-alkylcarbonylamino, optionally N-mono- or N,N-di-C1-8-alkylated amino or hydroxy or straight-chain omega-hydroxy-C1-8-alkyl.

REFERENCES:
patent: 5194605 (1993-03-01), Greenlee et al.
patent: 0 432 975 (1991-06-01), None
International Search Report dated Feb. 28, 2008 in the International (PCT) Application PCT/EP2007/060510 of which the present application is the U.S. National Stage.
PCT Written Opinion dated Feb. 28, 2008 in the International (PCT) Application PCT/EP2007/060510 of which the present application is the U.S. National Stage.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted 4-phenyl piperidines for use as renin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted 4-phenyl piperidines for use as renin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 4-phenyl piperidines for use as renin inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4130802

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.